Seattle Genetics Inc (SGEN) is traded on NASDAQ in USA. It is located in WASHINGTON, U.S.A and employs 759 people. Seattle Genetics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap
' category with current market capitalization of 9.13 B. Seattle Genetics Inc conducts business under Healthcare
sector and is part of Biotechnology
industry. This company has 143.03 M outstanding shares of which 10.98 M shares are at this time shorted by private and institutional investors with about 9.81 trading days to cover.
SEATTLE GENETICS currently holds about 452.41 M in cash with (154.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.16.
Check Seattle Genetics Probability Of Bankruptcy